Timing of Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation

Introduction to Anticoagulation Timing

The European Society of Cardiology recommends starting oral anticoagulation within 2-14 days after acute ischemic stroke in patients with atrial fibrillation, using a stroke severity-based algorithm, with mandatory brain imaging before initiation to exclude hemorrhagic transformation 1, 2

The American Heart Association suggests not initiating anticoagulation within 48 hours of acute ischemic stroke, as this significantly increases symptomatic intracranial hemorrhage risk without net benefit 3, 4, 1
Heparinoids should be avoided as bridging therapy in the acute phase because they increase symptomatic intracranial hemorrhage without improving outcomes 3, 2

For Transient Ischemic Attack (TIA), start anticoagulation 1 day after the event, after excluding intracranial hemorrhage with CT or MRI imaging, as recommended by the European Society of Cardiology 4, 1, 2
For mild stroke (NIHSS <8), start anticoagulation after 3 days from stroke onset, with repeat brain imaging at day 6 to evaluate for hemorrhagic transformation before initiating anticoagulation 1, 2
For moderate stroke (NIHSS 8-15), start anticoagulation after 6-8 days from stroke onset, with repeat brain imaging at day 6 to assess for hemorrhagic transformation 4, 1, 2
For severe stroke (NIHSS ≥16), start anticoagulation after 12-14 days from stroke onset, with repeat brain imaging at day 12 to exclude hemorrhagic transformation before starting anticoagulation 4, 1, 2

The American Heart Association strongly prefers DOACs (apixaban, dabigatran, edoxaban, or rivaroxaban) over warfarin for anticoagulation after stroke in atrial fibrillation patients, as DOACs reduce intracranial hemorrhage risk by approximately 56% compared to warfarin 4, 1, 2

Always obtain brain imaging (CT or MRI) before initiating anticoagulation to exclude hemorrhage, as recommended by the European Society of Cardiology 1, 2
For moderate-to-severe strokes, repeat imaging is essential to detect hemorrhagic transformation before starting DOACs 1, 2

Patients already on anticoagulation who experience stroke should have their anticoagulation interrupted for 3-12 days based on multidisciplinary assessment for moderate-to-severe strokes 1
Symptomatic hemorrhagic transformation requires delaying anticoagulation beyond 14 days and reassessing with repeat imaging 5

The risk of recurrent stroke in atrial fibrillation patients is 4.8% within the first 2 days and 0.4-1.3% per day in the first 7-14 days, highlighting the need for timely anticoagulation 1
The 2-week period after stroke carries both elevated recurrent ischemic stroke risk (8-10%) and symptomatic intracranial hemorrhage risk (2-4%), necessitating careful consideration of anticoagulation timing 1

Long-term oral anticoagulation is strongly recommended as secondary prevention in all atrial fibrillation patients with acute stroke without contraindications, regardless of whether sinus rhythm has been restored, as suggested by the American Heart Association 3, 4